MedPath

Effect if Simvastatin (Drug) in Liver Cirrhosis

Not Applicable
Conditions
Health Condition 1: K746- Other and unspecified cirrhosis ofliver
Registration Number
CTRI/2021/12/038917
Lead Sponsor
Institute of Liver and Biliary Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Diagnosed case of Hepato-pulmonary syndrome AaPO2 > 15 mm Hg on standing room air arterial blood gas (ABG). PaO2 <80 mmHg for clinical HPS between 18-70 years of years

2) Child A/B cirrhosis, Child C with CTP score of

more than equals to 10

3) Patient with no liver transplant option

Exclusion Criteria

1) Child-C cirrhosis CTP >10

2) Very Severe HPS

3) Acute-on-chronic liver failure

4) Thrombosis of splenoportal axis

5) Hepatocellular carcinoma

6) Renal dysfunction

7) Patients intolerant to beta blockers (history of hypotension or bradycardia)

8) Contraindication for beta-blockers (history of chronic obstructive pulmonary disease, atrioventricular block)

9) Pregnant females

10) Refusal to participate in the study

11) Hepatic Hydrothorax

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath